BioCryst Pharmaceuticals Inc (BCRX)
4.16
-0.05
(-1.19%)
USD |
NASDAQ |
Apr 25, 16:00
4.165
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Assets (Quarterly): 516.96M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 516.96M |
| September 30, 2023 | 522.92M |
| June 30, 2023 | 529.88M |
| March 31, 2023 | 509.74M |
| December 31, 2022 | 550.00M |
| September 30, 2022 | 558.59M |
| June 30, 2022 | 510.54M |
| March 31, 2022 | 527.72M |
| December 31, 2021 | 588.15M |
| September 30, 2021 | 265.76M |
| June 30, 2021 | 277.28M |
| March 31, 2021 | 284.43M |
| December 31, 2020 | 334.72M |
| September 30, 2020 | 176.23M |
| June 30, 2020 | 214.71M |
| March 31, 2020 | 136.59M |
| December 31, 2019 | 175.28M |
| September 30, 2019 | 90.50M |
| June 30, 2019 | 116.34M |
| March 31, 2019 | 142.34M |
| December 31, 2018 | 146.84M |
| September 30, 2018 | 168.31M |
| June 30, 2018 | 136.64M |
| March 31, 2018 | 155.37M |
| December 31, 2017 | 178.26M |
| Date | Value |
|---|---|
| September 30, 2017 | 191.49M |
| June 30, 2017 | 113.51M |
| March 31, 2017 | 129.51M |
| December 31, 2016 | 89.85M |
| September 30, 2016 | 91.50M |
| June 30, 2016 | 82.22M |
| March 31, 2016 | 102.88M |
| December 31, 2015 | 122.36M |
| September 30, 2015 | 138.96M |
| June 30, 2015 | 150.18M |
| March 31, 2015 | 129.87M |
| December 31, 2014 | 136.87M |
| September 30, 2014 | 137.12M |
| June 30, 2014 | 141.98M |
| March 31, 2014 | 43.39M |
| December 31, 2013 | 48.87M |
| September 30, 2013 | 53.20M |
| June 30, 2013 | 39.92M |
| March 31, 2013 | 46.90M |
| December 31, 2012 | 57.44M |
| September 30, 2012 | 64.09M |
| June 30, 2012 | 76.24M |
| March 31, 2012 | 80.08M |
| December 31, 2011 | 82.21M |
| September 30, 2011 | 92.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
90.50M
Minimum
Sep 2019
588.15M
Maximum
Dec 2021
362.44M
Average
334.72M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Electromed Inc | 46.96M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 972.49M |
| Shareholders Equity (Quarterly) | -455.53M |
| Debt to Equity Ratio | -1.781 |
| Current Ratio | 3.307 |
| Net Debt Paydown Yield | -1.58% |